|
Oct 10
|
Analysts Expect Breakeven For Percheron Therapeutics Limited (ASX:PER) Before Long
|
|
Aug 30
|
Percheron Therapeutics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
Aug 28
|
Investing in Percheron Therapeutics (ASX:PER) five years ago would have delivered you a 67% gain
|